Characterizing The Utilization of The Trillium Drug Program by An Oncology Patient Population
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.273
https://www.valueinhealthjournal.com/article/S1098-3015(17)30607-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
252
First Page :
A446
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30607-1&doi=10.1016/j.jval.2017.08.273